drugs – Stepping Stones Center

October 11, 2026· Applied Behavior Analysis

Scientists Identify Potential Breakthrough in Treating Brain Inflammation Using Existing Drugs

In a significant advancement for neurobiology, researchers at the University of Birmingham have unveiled a promising new strategy to curb harmful brain inflammation by targeting a specific receptor already susceptible to existing pharmacological interventions. This breakthrough, recently published in the journal Brain, centers on the P2X7 receptor, which the study identifies as a primary engine…

Standard

October 11, 2026· Applied Behavior Analysis

Breakthrough Study Identifies Potential Target to Curb Brain Inflammation Using Existing Drugs

Scientists at the University of Birmingham have unveiled a promising new strategy to mitigate harmful inflammation in the human brain. By targeting a specific receptor already known to science—and one that can be modulated using existing pharmacological agents—researchers believe they have opened a critical pathway toward treating a vast array of neurological and psychiatric conditions…

Standard

October 10, 2026· Applied Behavior Analysis

Scientists Identify New Therapeutic Pathway to Curb Brain Inflammation Using Existing Drugs

In a significant advancement for neurobiology, researchers at the University of Birmingham have unveiled a potential breakthrough in the treatment of chronic brain inflammation. By identifying a specific receptor that acts as a primary driver for neuroinflammatory processes, the team has paved the way for repurposing existing pharmaceutical agents to treat a wide array of…

Standard

October 9, 2026· Applied Behavior Analysis

Breakthrough Research Identifies Potential New Pathway for Treating Brain Inflammation Using Existing Drugs

In a significant development for neurology and psychiatry, a team of researchers at the University of Birmingham has identified a promising new strategy to curb harmful brain inflammation. The study, published in the journal Brain, points to the P2X7 receptor as a primary driver of neuroinflammatory processes. By successfully blocking this receptor in human brain…

Standard

October 9, 2026· Applied Behavior Analysis

Breakthrough Research Identifies New Target for Reducing Brain Inflammation Using Existing Drugs

In a significant development for neurological medicine, researchers at the University of Birmingham have unveiled a potential new strategy to curb harmful neuroinflammation—a condition that underpins some of the most challenging brain disorders in modern medicine. By targeting a specific receptor known as P2X7, which is already the subject of existing pharmaceutical research, the team…

Standard

October 2, 2026· Applied Behavior Analysis

Beyond Weight Loss: How GLP-1 Drugs Are Redefining the Neuroscience of Addiction

For the average person, the mere thought of a savory, flame-grilled burger or the crisp, refreshing taste of a cold pint of beer can trigger a vivid, almost sensory mental image. This isn’t just a fleeting fancy; it is a powerful driver of behavior. This intrinsic link between thinking and doing serves a vital biological…

Standard

September 24, 2026· Applied Behavior Analysis

Beyond Weight Loss: How GLP-1 Drugs Are Unlocking the Neural Mystery of Cravings

For most of us, the mere thought of a sizzling burger or a cold pint of beer on a summer afternoon triggers a vivid, almost visceral mental image. This reaction is more than just a fleeting desire; it is a powerful, evolved mechanism that drives behavior. This fundamental link between thinking and doing serves a…

You May Have Missed